Valeant To Present At The 36th Annual J.P. Morgan Healthcare Con

Valeant To Present At The 36th Annual J.P. Morgan Healthcare Conference

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

SOURCE Valeant Pharmaceuticals International, Inc.

LAVAL, Quebec, Jan. 3, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 10, 2018, at 10:30 a.m. PST (1:30 p.m. EST).

A live webcast and audio archive of the event will be available on the Investor Relations page of the Valeant web site at:

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Investor Contact:       

Media Contact:

Arthur Shannon         

Lainie Keller

(514) 856-3855                  

(908) 927-0617

(877) 281-6642 (toll free)       


Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.) (PRNewsFoto/)


Cision View original content with multimedia:

©2017 PR Newswire. All Rights Reserved.

Powered by Frankly